Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00556530Recruiting

Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome

Role: collaborator

NCT07044804Not ApplicableRecruiting

Non-Invasive Brain Stimulation to Improve Language in Down Syndrome.

Role: collaborator

NCT06692946Not ApplicableCompleted

Clinical Efficacy of Cooperative Parent-Mediated Therapy (C-PMT_in_ASD)

Role: collaborator

NCT06310109Not ApplicableRecruiting

Effect of Pediatric Intensive Care Unit Diaries on PICS-p

Role: lead

All 4 trials loaded